Franco Indian Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 38 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 5.91%
(FY 2023)
- Profit 11.08%
(FY 2023)
- Ebitda 4.18%
(FY 2023)
- Net Worth 3.99%
(FY 2023)
- Total Assets 4.00%
(FY 2023)
About Franco Indian Therapeutics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pascal Postel, Lalsa Yadav, Dinesh Jain, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232WB1986PTC040635
- Company No.
040635
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 1986
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Franco Indian Therapeutics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pascal Postel  | Director | 02-Jan-2021 | Current |
| Lalsa Yadav | Director | 18-Aug-1987 | Current |
| Dinesh Jain | Director | 14-Apr-2009 | Current |
| Rajesh Singh | Director | 25-Jan-2018 | Current |
| Manish Sinha | Director | 25-Jan-2018 | Current |
Financial Performance of Franco Indian Therapeutics.
Franco Indian Therapeutics Pvt. Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 5.91% increase. The company also saw a substantial improvement in profitability, with a 11.08% increase in profit. The company's net worth moved up by a moderate rise of 3.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Franco Indian Therapeutics?
In 2023, Franco Indian Therapeutics had a public holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Franco Indian Medicare Pvt LtdActive 41 years 6 monthsPascal Postel, Lalsa Yadav and 2 more are mutual person
- Franco-Indian Pharmaceuticals Private LimitedActive 65 years 7 months
Pascal Postel and Lalsa Yadav are mutual person
- Franco Indian Research Private LimitedActive 51 years 9 months
Pascal Postel, Lalsa Yadav and 2 more are mutual person
Princeps Pharmaceuticals Private LimitedActive 24 years 8 monthsPascal Postel, Lalsa Yadav and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Franco Indian Therapeutics?
Unlock and access historical data on people associated with Franco Indian Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Franco Indian Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Franco Indian Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
